BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Cempra Pharmaceuticals, Inc.'s Fusidic Acid (TAKSTA(TM), CEM-102) is Active, In Vitro, Against Methicillin-Resistant Staphylococcus Aureus (MRSA) Strains Isolated from Cystic Fibrosis Patients

  April 28, 2011

   · 

  5 min read
• Genetown

  Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage Medical, Inc.'s System One(TM) is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis

  April 28, 2011

   · 

  4 min read
• Business

  Cardinal Health, Inc. FY 3Q Profit Rises 11%

  April 28, 2011

   · 

  8 min read
• Biotech Bay

  MAP Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

  April 28, 2011

   · 

  1 min read
• Drug Development

  Shire plc Reports Positive Results from Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) as Adjunctive Treatment in Predominant Negative Symptom Schizophrenia

  April 28, 2011

   · 

  14 min read
• BioForest

  TapImmune Inc. to Present at Aegis Capital Emerging Growth Conference in Las Vegas on April 30, 2011

  April 28, 2011

   · 

  1 min read
• Business

  Shire plc Says Strong Q1 Underpins 2011 Guidance

  April 28, 2011

   · 

  9 min read
• Drug Development

  ISTA Pharmaceuticals, Inc. Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis

  April 28, 2011

   · 

  8 min read
• Policy

  Merck & Co., Inc. Wins Unanimous FDA Panel Support for Blockbuster Boceprevir

  April 28, 2011

   · 

  4 min read
• Business

  Sanofi-Aventis (France) Offers Bonuses to Retain Genzyme Corporation Scientists

  April 28, 2011

   · 

  1 min read